X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2111) 2111
Book Review (246) 246
Publication (85) 85
Magazine Article (7) 7
Book Chapter (6) 6
Book / eBook (4) 4
Conference Proceeding (4) 4
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2086) 2086
index medicus (1826) 1826
exanthema - chemically induced (1792) 1792
female (1240) 1240
male (1170) 1170
middle aged (902) 902
adult (857) 857
aged (651) 651
drug eruptions - etiology (441) 441
dermatology (301) 301
exanthema (299) 299
treatment outcome (298) 298
oncology (281) 281
adolescent (238) 238
antineoplastic agents - adverse effects (227) 227
exanthema - pathology (224) 224
rash (224) 224
aged, 80 and over (219) 219
abridged index medicus (217) 217
exanthema - diagnosis (209) 209
child (199) 199
pharmacology & pharmacy (186) 186
immunology (183) 183
allergy (178) 178
skin (172) 172
diagnosis, differential (162) 162
retrospective studies (157) 157
therapy (152) 152
medicine, general & internal (140) 140
drug hypersensitivity - etiology (136) 136
antineoplastic agents - therapeutic use (135) 135
drug eruptions - pathology (135) 135
care and treatment (134) 134
cancer (132) 132
fever - chemically induced (132) 132
anti-bacterial agents - adverse effects (131) 131
acute disease (130) 130
exanthema - drug therapy (130) 130
chemotherapy (127) 127
drug eruptions - diagnosis (127) 127
receptor, epidermal growth factor - antagonists & inhibitors (127) 127
risk factors (126) 126
quinazolines - adverse effects (121) 121
lung neoplasms - drug therapy (119) 119
young adult (118) 118
diarrhea - chemically induced (117) 117
anticonvulsants - adverse effects (116) 116
infectious diseases (116) 116
child, preschool (114) 114
antibodies, monoclonal - adverse effects (112) 112
time factors (110) 110
carcinoma, non-small-cell lung - drug therapy (109) 109
drug therapy (104) 104
follow-up studies (101) 101
skin - pathology (100) 100
antineoplastic combined chemotherapy protocols - therapeutic use (99) 99
cetuximab (99) 99
protein kinase inhibitors - adverse effects (99) 99
skin diseases, vesiculobullous - chemically induced (99) 99
dose-response relationship, drug (98) 98
side effects (95) 95
syndrome (94) 94
complications and side effects (93) 93
eosinophilia - chemically induced (93) 93
hypersensitivity (93) 93
administration, oral (91) 91
toxicity (89) 89
antineoplastic combined chemotherapy protocols - adverse effects (88) 88
hiv infections - drug therapy (88) 88
drug therapy, combination (86) 86
pruritus - chemically induced (86) 86
exanthema - epidemiology (83) 83
drug hypersensitivity (81) 81
medicine & public health (81) 81
research (80) 80
safety (79) 79
drug hypersensitivity - diagnosis (78) 78
trial (78) 78
skin tests (77) 77
erlotinib (75) 75
infant (75) 75
erlotinib hydrochloride (74) 74
efficacy (73) 73
management (73) 73
nausea - chemically induced (71) 71
pediatrics (70) 70
quinazolines - therapeutic use (70) 70
animals (69) 69
antibodies, monoclonal, humanized (69) 69
neoplasms - drug therapy (69) 69
skin diseases (68) 68
drug administration schedule (67) 67
drugs (66) 66
exanthema - immunology (66) 66
urticaria - chemically induced (66) 66
incidence (65) 65
patch tests (65) 65
disease-free survival (64) 64
severity of illness index (64) 64
toxic epidermal necrolysis (64) 64
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1774) 1774
German (152) 152
French (53) 53
Chinese (44) 44
Spanish (27) 27
Japanese (21) 21
Dutch (11) 11
Norwegian (10) 10
Danish (9) 9
Swedish (4) 4
Czech (3) 3
Hungarian (3) 3
Italian (3) 3
Serbian (3) 3
Croatian (2) 2
Portuguese (2) 2
Finnish (1) 1
Polish (1) 1
Russian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 03/2011, Volume 364, Issue 12, pp. 1134 - 1143
Journal Article
Blood, ISSN 0006-4971, 08/2014, Volume 124, Issue 7, pp. 1038 - 1046
Journal Article
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 07/2018, Volume 32, Issue 7, pp. 339 - 343
Journal Article
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 04/2001, Volume 103, Issue 14, pp. 1838 - 1843
Background-Heparin-induced thrombocytopenia (HIT) is an immune-mediated syndrome caused by heparin. Complications range from thrombocytopenia to... 
Anticoagulants | Inhibitors | Heparin | Platelets | Thrombosis | heparin | ANTIBODIES | inhibitors | RECOMBINANT HIRUDIN | CARDIAC & CARDIOVASCULAR SYSTEMS | thrombosis | anticoagulants | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | platelets | AGE | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1621 - 1634
The addition of the oral proteasome inhibitor ixazomib to a regimen of lenalidomide plus dexamethasone led to a significant prolongation of progression-free... 
SUPERIORITY | MEDICINE, GENERAL & INTERNAL | CARFILZOMIB | RANDOMIZED PHASE-3 | THERAPY | PROTEASOME INHIBITOR MLN9708 | QUALITY-OF-LIFE | BORTEZOMIB | THALIDOMIDE | ANTITUMOR-ACTIVITY | TRANSPLANTATION | Glycine - analogs & derivatives | Glycine - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Boron Compounds - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Exanthema - chemically induced | Aged, 80 and over | Adult | Glycine - administration & dosage | Dexamethasone - administration & dosage | Double-Blind Method | Administration, Oral | Kaplan-Meier Estimate | Proportional Hazards Models | Thrombocytopenia - chemically induced | Thalidomide - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Boron Compounds - adverse effects | Aged | Care and treatment | Dosage and administration | Dexamethasone | Multiple myeloma | Thrombocytopenia | Inhibitor drugs | Risk groups | Drug therapy | Peripheral neuropathy | Survival | Patients | Drug dosages | Proteasome inhibitors | Quality of life | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2016, Volume 34, Issue 29, pp. 3562 - 3569
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 15, pp. 1408 - 1418
Among men with nonmetastatic prostate cancer who had a rapid PSA doubling time and were receiving androgen-deprivation therapy, the median metastasis-free... 
MEDICINE, GENERAL & INTERNAL | THERAPY | LIGANDS | BONE METASTASES | MEN | ARN-509 | ANTIGEN | Prostate-Specific Antigen | Double-Blind Method | Humans | Middle Aged | Proportional Hazards Models | Male | Prostatic Neoplasms, Castration-Resistant - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Prostatic Neoplasms, Castration-Resistant - pathology | Disease-Free Survival | Thiohydantoins - adverse effects | Exanthema - chemically induced | Neoplasm Metastasis - prevention & control | Thiohydantoins - therapeutic use | Aged, 80 and over | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Prostate cancer | Care and treatment | Metastasis | Medical research | Antigens | Lymphatic system | Medical imaging | Prostate-specific antigen | Research & development--R&D | Family medical history | Hypothyroidism | Survival | Patients | Metastases | Androgens | Hospitals | Castration | Prostate | Index Medicus | Abridged Index Medicus | Adenocarcinoma | pathology | Androgen Antagonists | Exanthema | 80 and over | Prostatic Neoplasms | Neoplasm Metastasis | Thiohydantoins | Urologi och njurmedicin | drug therapy | chemically induced | Castration-Resistant | prevention & control | secondary | adverse effects | Urology and Nephrology | therapeutic use
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 11, pp. 1014 - 1024
Journal Article